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Abstract
Background: Dengue virus (DENV) is a member of the Flaviviridae family, transmitted to human via mosquito.
DENV infection is common in tropical areas and occasionally causes life-threatening symptoms. DENV contains a
relatively short positive-stranded RNA genome, which encodes ten viral proteins. Thus, the viral life cycle is
necessarily rely on or regulated by host factors.
Methods: In silico analyses in conjunction with in vitro kinase assay were used to study kinases that potentially
phosphorylate DENV NS5. Potential kinase was inhibited or activated by a specific inhibitor (or siRNA), or an
activator. Results of the inhibition and activation on viral entry/replication and host cell survival were examined.
Results: Our in silico analyses indicated that the non-structural protein 5 (NS5), especially the RNA-dependent RNA
polymerase (RdRp) domain, contains conserved phosphorylation sites for protein kinase C (PKC). Phosphorylation of
NS5 RdRp was further verified by PKC in vitro kinase assay. Inhibitions of PKC by a PKC-specific chemical inhibitor or
siRNA suppressed NS5 phosphorylation in vivo, increased viral replication and reduced viability of the DENV-infected
cells. In contrary, activation of PKC effectively suppressed intracellular viral number.
Conclusions: These results indicated that PKC may act as a restricting mechanism that modulates the DENV
replication and represses the viral outburst in the host cells.
Keywords: Dengue virus (DENV), Protein kinase C (PKC), Phosphorylation, Non-structural protein 5 (NS5), Viral
replication, Flavivirus
Background
DENV infection is among major life-threatening infec-
tious diseases in tropical countries. A fraction of infected
human will develop severe life-threatening symptoms,
which are recognized as dengue hemorrhagic fever
(DHF). This composes of bleeding, low levels of blood
platelets and blood plasma leakage. It can develop into
dengue shock syndrome (DSS), where dangerously low
blood pressure occurs. These are normally followed by
mortality, since there is no specific management for it,
except the symptomatic treatments. Currently, there is
no effective vaccine that can prevent the infection.
Therefore, information on the pathogenesis and the biol-
ogy of the virus is required to build novel strategies to
reduce the death rate caused by this virus.
DENV is a relatively simple virus. Its genome encodes
10 viral proteins, including 3 structural proteins; enve-
lope (E), capsid, prM, and 7 non-structural (NS) pro-
teins; NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5.
To reproduce in the host cells, DENV requires host’s
components to propagate [1–4]. Thus, virus-host inter-
action is one of the major processes that influence viral
life cycle, and is being extensively investigated.
Accumulating evidences have shown that many viral
proteins interact with host proteins. Viral proteins, such
as NS1, NS4A, NS5, E, and capsid, were demonstrated by
yeast two-hybrid or by co-immunoprecipitation coupled
with Mass spectrometry to physically associate with host
proteins [5–7]. Many of these interactions were proven to
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be physiologically relevant [6, 8, 9]. Functional interac-
tions, such as phosphorylation and methylation, are also
subjected for examinations. Recent evidences indicated
that host proteins functionally interact with, and regulate
the viral proteins, and vice versa [10–13].
NS5s from various flaviviruses have long been distinct-
ively characterized as a phosphoprotein which contains
several possible phosphorylation sites [14], suggesting a
significance of this phospho regulation for the viruses.
The protein is composed of 2 functional domains,
namely the N-terminal methyltransferase, which cata-
lyzes guanine N-7 and ribose 2’-OH methylations of the
5’ terminal cap 1 structure (m7GpppAmG) during viral
cap formation [15], and the C-terminal RNA-dependent
RNA polymerase (RdRp), which is an enzyme that syn-
thesizes viral RNAs during viral replication [16].
Identification of kinases that responsible for the phos-
phorylation has been a topic of interest. Recent reports
showed that NS5 is phosphorylated by Casein Kinase I
(CK I) or protein kinase G (PKG) at the methyltransfer-
ase domain [10, 17]. The phosphorylations appeared to
be essential for the normal function of NS5, since block-
ing the phosphorylation either by chemical inhibitor or
amino acid substitution of the potential phosphorylation
site suppressed viral replication and viral production
[17]. These findings also suggested that NS5 is a central
protein, which mediates functional interactions between
host and virus proteins. Detailed study of NS5 phosphor-
ylation may provide a better understanding of the viral
life cycle, and may lead to intervention approaches that
are based on viral-host interaction. In this study, we per-
formed in silico analyses to identify human kinases that
potentially regulate DENV2 NS5. We identified that there
were several possible PKC phosphorylation sites on the
NS5. We then also studied the physiological relevance of
the phosphorylations for the virus and host cells.
Results
NS5 contains possible protein kinase C phosphorylation
sites
To investigate possible amino acids on NS5 that might be
phosphorylated by human kinases, we analyzed amino
acid sequence of dengue serotype 2 (DENV2) NS5 by
three phospho-algorithms; Scansite™ [18], NetPhosK 2.0
[19], and KinasePhos 2.0 [20]. In accordance with the
previous notion describing NS5 as phosphoprotein, the
analyses revealed many potential candidate phosphoryl-
ation sites on NS5 for several kinases, when compared
to other DENV proteins (Fig. 1a). Protein kinases pre-
dicted to phosphorylate NS5 by at least one algorithm
included PKC, PKA, CDKs (CDCs), MAPK, ATM, CK
II, PKB, and others (Fig. 1a). Our analyses also identi-
fied 2 kinases that were previously reported to phos-
phorylate NS5, i.e. Casein Kinase I (CK I), and protein
kinase G (PKG) [10, 17, 21]. Among the candidates, we
focused on possible functional interaction between NS5
and PKC (predicted by all 3 algorithms). We found that
4 potential phosphorylation sites, in particular Thr244,
Thr302, Ser796, and Ser885, were recognized by at least
2 predicting algorithms on DENV2 NS5. Among the 4
candidates, Thr302 and Ser796 are conserved in all
vector-borne flaviviruses (Fig. 1b). Thr244, and Ser885
were not in the other mosquito-borne or tick-borne
viruses, but were rather limited within the DENVs
(Fig. 1b). While Thr244 resides in the methyltransferase
domain of NS5, Thr302 Ser796 and Ser885 reside in
the RdRp domain of NS5. These 4 candidate sites are
exposed to solvent, thus, are potentially be phosphory-
lated (Fig. 1b, c).
Since RdRp domain contains several of the possible
phosphorylation sites for PKC, we set up a PKC in vitro
kinase assay using purified recombinant DENV2 RdRp
domain, containing Thr302 Ser796 and Ser885, as a
substrate. The kinase assay showed that PKC efficiently
phosphorylated RdRp in vitro. The signal was approxi-
mately 9 folds higher than that of GST (used as non-
relevant control). Under these conditions, PKC kinase
assay gave a very low signals for the other DENV pro-
teins, such as capsid, prM, E, NS1, NS2B, NS3, NS4B
(Fig. 1d). Interestingly, protein kinase C appeared to
produce relatively high phosphorylation signal com-
pared with the other potential NS5 kinases, namely
PKA, CK I, and CDK4/cyclinD1 (Fig. 1e). Thus, PKC
can efficiently phosphorylated the NS5 RdRp domain in
vitro. Of note, although the methyltransferase domain
contains only one possible PKC phosphorylation site,
Thr244, which is not conserved in all of the vector-
borne flaviviruses, it is entirely possible that this site
may be phosphorylated by PKC. We have yet to test
this possibility.
Silencing of PKCα reduced Ser and Thr phosphorylation
of NS5 in vivo
To investigate the functional interaction between host
PKC and DENV NS5 in vivo, we depleted PKCα using
PKCα-specific siRNAs and examined the level of NS5
phosphorylation in vivo. We first, tested the efficiency of
siRNA-mediated PKC depletion. We found that at 24,
48, and 72 h after PKC-specific siRNA transfection,
more than 70 % of the endogenous PKC levels were
downregulated (Fig. 2a), while host cell viability was un-
affected (data not shown). We selected to examine NS5
phosphorylation at the 24 h after siRNA transfection.
We expressed His-FLAG-tagged NS5 in host cells by
infecting the cells with recombinant DENV expressing
the His-FLAG-NS5 protein (etDENV), then pulled down
the NS5 using anti-FLAG antibody. The phosphorylation
on the His-FLAG-NS5 was analyzed by anti phospho-
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Ser and phospho-Thr immunoblottings. We found that
under this condition, silencing of the PKC clearly de-
creased Serine and Threonine phosphorylations of NS5
(Fig. 2b, c).
Inhibition of PKC by BisI reduced Ser and Thr
phosphorylation of NS5 in vivo
To confirm the effect of PKC depletion on NS5 phos-
phorylation, we inhibited PKC activity of host cells using
bisindolylmaleimide I (BisI), a specific chemical inhibitor
of conventional and novel PKCs. We found that various
concentrations of BisI, (up to 1 μM of BisI) were not
toxic to the cells for at least up to 72 h (Fig. 3a). As early
as 24 h after treatment, 0.1 and 1 μM of BisI clearly sup-
pressed the activity of PKC, as indicated by a complete
loss of the phosphorylation of PEA15, an established
PKC substrate (Fig. 3b, c). Importantly, FLAG immuno-
precipitation of the tagged-NS5 followed by phospho-Ser
or phospho-Thr immunoblotings showed that Serine
and Threonine phosphorylations were decreased, when
the cells were treated with non-toxic dose (1 μM) of BisI
(Fig. 3d, e).
PKC blockage enhanced DENV viral replication, but not
viral entry into host cells
To examine the biological effects of PKC blockage on
the viral replication, we quantitated the viral copy num-
ber in the host cells pre-treated with BisI using RT-
qPCR. BisI, which blocked the PKC activities, signifi-
cantly increased the viral copy of DENV2 strain 16681
in human hepatocellular carcinoma HepG2 cells, with
the highest copy number of the virus attained by the
0.1 and 1 μM BisI treatments (Fig. 4a). On the contrary,
we detected a very lowering of dengue virus copy
number in HepG2 cells pretreated with 0.1 nM of a
PKC activator Phorbol 12-myristate 13-acetate (PMA)
(Fig. 4b). We found that, at this dose of PMA, activity
of PCK was induced indicated by an upregulation of
phospho-PEA15 (Fig. 4c).
To further investigate whether the PKC inhibitor al-
tered DENV entry into the host cells, we assessed the
viral copy number in the cells at early time points, i.e. at
2, 5 and 8 h after viral infection. During these time
points, the viral replication was not yet fully operated.
Therefore, the viral copy number would represent the
number of virus entering the host cells after the infec-
tions [22]. We found that the amounts of virus in BisI-
treated cells were comparable to those in the vehicle-
treated cells, during these early time points (Fig. 4d).
Therefore, it is likely that the activity of PKC was not
involved with DENV entry into the host cells, and inhib-
ition of PKC activity does not interfere with this process.
In contrast to the results from early time points, viral
copy numbers at the later time points were augmented
by at least 10 folds (after 12 h of BisI-treatment), when
compared to that of the vehicle-treated cells. The viral
copy numbers continued to be higher at every time
point examined until 72 h post infection (Fig. 4e).
These results indicated that inhibition of the PKC ac-
tivity promotes viral replication, showing in an increase
of the viral copy number, whereas stimulation of the
PKC activity may be involved in suppression of the
DENV replication in the host cells.
Promotion of the viral replication by PKC blockage
was also confirmed using siRNA-mediated silencing of
PKCα. This also resulted in a significant increase of den-
gue viral copy number and the amounts of viral NS5
and NS3 proteins in host cells (Fig. 5a, b). Although not
statistically significant, we detected an increase of se-
creted virus into the culture medium of BisI-treated cells
as well (Fig. 5c).
Inhibition of PKC reduced host cell viability
The above data showed that depletion of PKC signifi-
cantly enhanced the dengue viral replication in the host
cells. To further assess whether PKC depletion also had
an effect on the host cells, we monitored growth of the
infected HepG2 cells in the presence or absence of PKC
(See figure on previous page.)
Fig. 1 In silico analyses revealed possible protein kinase C phosphorylation sites on dengue NS5. a Prediction of possible NS5 kinases. A heat map
showed possible human kinases that phosphorylate DENV2 NS5 based on in silico predictions by Scansite™, NetPhosK 2.0, and KinasePhos 2.0
(upper panel). Names of possible kinases were listed vertically on the right of the panel. DENV2 proteins were listed horizontally on the top. Color
codes (lower panel) indicated numbers of hit from the predicting algorithms; from 0 (very light red) to 3 (dark red). b Sequence
conservation of the predicted PKC phosphorylation sites across flaviviruses. Partial amino acid sequences of flaviviruses were listed as indicated by name;
Omsk hemorrhagic fever virus (OHFV), Gadgets Gully virus (GGYV), Kama virus (KAMV), and tick-borne encephalitis virus (TBV), St. Louis encephalitis virus
(SLEV), dengue 1–4 (DENV1–4), West Nile virus (WNV), yellow fever virus (YFV), Zika virus (ZIKA), Japanese Encephalitis virus (JEV). Predicted
PKC phosphorylation sites were showed in RED. In addition, Thr302, and Ser796 that were conserved were underlined. c Three-dimension
models of DENV2 NS5 protein. Colored in light gray is the methyltransferase domain, dark gray is the RNA-dependent RNA polymerase (RdRp) domain.
Highlighted in yellow, red, and blue are possible PKC phosphorylation sites; Thr244, Ser796, andThr302, respectively. Highlighted in fluorescent green is
the GDD RNA polymerase active site. d PKC in vitro kinase assays. Purified DENV2 proteins were used as substrate. Purified GST was used as a
non-relevant control for the reaction. Bars represented means of 3 independent experiments, error bars; S.D. e In vitro kinase assays, several hu-
man kinases were tested including PKC, PKA, CKI, and CDK4/cyclin D1, as indicated. The signal was normalized by the signal from reactions
with GST. Bars represented data from a representative experiment
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depletion. To this end, HepG2 cells, which either pre-
treated with non-targeting (control) siRNA or PKC-
specific siRNA, were infected with DENV2 16681. We
found that, viability of the non-targeting siRNA-treated
control cells without viral infection consistently in-
creased over 3 days (Fig. 5d, dashed black line). Infection
of dengue virus, or PKC siRNA transfection alone, sig-
nificantly reduced HepG2 cell viability by 72 h after the
PKC knockdown (Fig. 5d, dashed red line and solid black
line, respectively). Importantly, depletion of PKC by
siRNA together with DENV-infection accelerated sup-
pression of HepG2 cell viability to 48 h after transfec-
tion. The loss of host cells became more clearly evident
at the 72 h time point (Fig. 5d, solid red line). Inhibition
of PKC by BisI also caused a marked reduction of host
cell viability at 48 h after DENV infection (Fig. 5e).
Fig. 2 Inhibitions of PKC by PKCα siRNA or a chemical inhibitor (BisI) suppressed NS5 RdRp phosphorylations. a PKCα-specific siRNA depleted
endogenous PKCα at 24, 48, 72 h after siRNA transfection. A pool of PKCα siRNAs (siPKCα) was transfected into the BHK-21 cells. The levels of
PKCα were detected by PKCα immunoblotting. A non-targeting siRNA (siNeg) was used as a control. GAPDH immunoblots were used as a loading
control. b PKCα depletion by siRNA downregulated NS5 Threonine and Serine phosphorylations. BHK-21 cells were infected with recombinant DENV
expressing His-FLAG-tagged NS5. The His-FLAG-tagged NS5 was pulled down (IP) from BHK-21 cell lysate by anti-FLAG antibody, and Threonine/Serine
phosphorylations (p-Thr/p-Ser) were examined by p-Thr or p-Ser-specific antibodies. c Quantifications of p-Thr/NS5 and p-Ser/NS5 from (b)
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Altogether, these data indicated that inhibition of PKC
led to an enhancement of the DENV growth and sup-
pression of host cell viability.
Discussion
Significance of the interaction between virus and host
cells have been established, especially that of positive-
strand RNA viruses, such as the DENV and the host
cells. The simplicity of the viruses, and limited num-
ber of viral proteins have made the host factors indis-
pensable for the virus. Physical interactions between
host proteins and several viral proteins have been
widely studied. Yeast-two-hybrid and immunoaffinity-
purification/Mass spectrometry experiments revealed
extensive physical networks of viral-host interactomes
[23]. Biochemical reactions between biomolecule are
often transient, and sometimes fastidiously hard to de-
tect. Hence, there are fewer numbers of report de-
scribing functional interactions among the host-viral
proteins. However, functional interactions are of im-
portance, since all of them are virtually regulative and
physiologically meaningful for the co-existing of the
virus and the host cell.
In this study, we used an in silico screening approach,
which relied on three different phospho-scanning tools,
to search for novel phosphor regulatory sites on DENV
NS5 protein. None of the screening tools to these days
can accurately predict phosphorylation for all kinases.
Fig. 3 Inhibition of PKC by BisI. a Inhibition of PKC by BisI did not alter host cell growth. HepG2 cells were treated with various concentrations of
BisI. Average cell viability from right after the treatment (0 h), 24, 48, and 72 h was monitored by MTT assays. Error bars represented S.D. from 3
independent experiments. b BisI effectively inhibited PKC activity. Phosphorylation of PEA15, a known substrate of PKC. Levels of phospho-PEA15
at 24 h after BisI treatment were examined by immunoblotting using a phospho-PEA15 (p-PEA15) specific antibody. Concentrations of BisI used
were indicated. PEA15 immunoblot was used to examine the total amount of PEA15. c Quantification of p-PEA15 from b Amounts of p-PEA15
were normalized by total PEA15. d PKC inhibition by 1 μM of BisI downregulated NS5 Threonine and Serine phosphorylations. BHK-21 cells were
infected with recombinant DENV expressing His-FLAG-NS5, and tagged protein was then pulled down by anti-FLAG antibody. The p-Thr and p-Ser
were examined by immunobloting as in Fig. 2b. Arrow heads indicated specific p-Thr or p-Ser signals. e Quantifications of p-Thr/NS5 and p-Ser/NS5
from (d)
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Fig. 4 PKC activity restricted DENV viral number in host cells. a Viral copy numbers in HepG2 cells treated with various BisI concentrations. Cells
were treated with various concentrations of BisI for 30 min, prior to a 1.5-h infection by DENV strain 16681. Cells were kept in medium with BisI
for a total of 24 h, before harvesting. Viral copy numbers were quantified by quantitative PCR. Bars represent means viral copy number from 3
independent experiments. Error bars represent S.D., **; p-value ≤ 0.01. Concentrations of BisI used were not toxic to the host cells. b Reduction of
DENV copy number in host cells by PKC activator. HepG2 cells were treated with 0.1 nM of a PKC activator PMA or vehicle for 30 min, prior to a
2-h infection by DENV strain 16681 (MOI of 5). Cells were then kept in the activator (or vehicle) for 24 h before harvesting to quantify the viral
copy numbers. Bars represent means of 3 independent experiments. Error bars represent S.D., **; p-value ≤ 0.01. c PMA promoted PKC activity.
Levels of total PEA15 and phospho-PEA15 at 24 h after PMA treatment were examined using immunoblotting (left panel). Ratios of the signals
p-PEA15/PEA15 from the immunoblots were shown on the right. d BisI had no effect on entering of virus in to the host cells (HepG2). Average
viral copy numbers at the early time points after viral infection, 2, 5, 8 h. Viral infection and BisI treatment was performed as indicated in a Three
independent experiments were performed. Error bars represent S.D. e DENV copy numbers in HepG2 cells during indicated time pointed were
represented as mean of 3 independent experiments. Error bars represent S.D., *; p-value≤ 0.05, **; p-value≤ 0.01. BisI treatment and viral infection
was performed as indicated in (a)
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This is because many kinases do not have a clear con-
sensus site. Thus, we incorporated results from all of the
tools, hoping to identify the most possible phospho-
sites on the DENV proteins. From our in silico analyses,
we found that despites NS5, capsid was also predicted
as a potential substrate for PKC (Fig. 1a). However, in a
subsequent experiment, capsid was shown to be a poor
PKC substrate in the in vitro kinase assay. This impli-
cated that a verification of the in silico prediction is
indispensable.
Fig. 5 Depletion of PKC increased viral-induced host cell damage. a siRNA-mediated depletion of PKCα resulted in increased intracellular DENV
copy number. HepG2 cells were transfected with PKCα-specific siRNA (siPKCα) or non-targeting siRNA (siNeg) for 24 h prior to a 2-h infection of
DENV strain 16681. After 24 h, cells were harvested. PKCα mRNA and DENV viral copy numbers were quantified by quantitative PCR. Left; bars
represent viral copy numbers in the host cells treated with siRNA indicated. Right; bars represent means expressions of PKCα mRNA from 3
independent experiments. Error bars represent S.D., *; p-value≤ 0.05. b Expressions of PKCα, DENV NS3, and NS5 were examined by immunoblots
using indicated antibodies. GAPDH immunoblot was used as loading control. c Average DENV viral copy numbers in culture mediums from
PKCα-depleted HepG2 cells (siPKCα), compared to control cells (siNeg). Bars represent means of 3 independent experiments. Error bars represent S.D.
The viral copy numbers were determined by RT-qPCR. d Depletion of PKCα decreased the viability of DENV-infected cells. HepG2 cells were treated as
indicated. The 24 h post transfection, cells were infected with DENV. Cell viabilities were examined using MTT assay. Graphs showed average
of 3 independent experiments. Error bars represent S.D. *; p-value ≤ 0.05, **; p-value ≤ 0.01. e Inhibition of PKC by BisI decreased viability of
DENV-infected cells. HepG2 cells were treated with 1 μM BisI for 30 min, prior to a 2-h infection by DENV strain 16681. Cell viabilities were
determined by tryptan blue staining at indicated time points. Bars represent means of 3 independent experiments. Error bars represent S.D.,
*; p-value ≤ 0.05
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Flaviviral NS5 was shown to be a phosphoprotein and
is regulated by human kinases [11, 17]. Phosphorylation
by host factors in many cases are required for normal
function of NS5 proteins, for example phosphorylation
of NS5 was shown to involve with NS3-NS5 complex
formation [12]. PKG-NS5 interaction is required for viral
replication [17, 21]. This interaction was shown to be in-
volved with the NS5 methyltransferase domain. CK I
was also shown to phosphorylate the same domain on
NS5 and regulate methyltransferase function, hence the
production of virus in the host cells [10].
On the other hand, some NS5 phosphorylations have
been shown to inhibit the function of NS5. Previous re-
port has shown that the NS5 methyltransferase function
of Yellow fever virus (YFV) was suppressed by phos-
phorylation [24].
In addition, the RdRp domain on NS5 was predicted
to be phosphorylated by CK II on residues distinct from
those phosphorylated by PKC. The CK II phosphoryl-
ation site was located in the 37-amino-acid linker inter-
domain of NS5 (residues 369 to 405), which contains the
nuclear localization signal (NLS). Phosphorylation at this
site has been shown to inhibit of NS5 nuclear targeting,
resulting in retention of the RdRp in the cytoplasm [11].
Here, we showed that phosphorylation in the NS5 by
PKC is inhibitory and is physiologically relevant. Inhib-
ition of this phosphorylation reaction resulted in a sig-
nificant increase of viral number and reduction of host
cell viability. Conversely, activation of PKC by PMA
suppressed intracellular DENV production. Thus, it is
possible that PKC might represent an intracellular
restricting mechanism that prevents viral outburst in
the host cells. In accordance with our result, a recent
report showed that a siRNA screening identified PIKC1,
an protein kinase Cα-interacting protein as a host fac-
tor that restricting DENV virus [25].
In this study, we have shown by in vitro kinase assay
that the RdRp domain within NS5 was a substrate for
PKC. This domain contains three PCK phosphorylation
sites (Thr302, Ser796, and Ser885). We hypothesized
that some of the PKC phosphorylation sites might be
regulatory site for RdRp’s function. For example, Ser796,
is located near the active site of the RNA polymerase
(GDD site) (Fig. 1c) [26]. Thus, hyperphosphorylation
of these sites by PCK may interfere with the RNA poly-
merase function of NS5 RdRp, leading to suppression
of DENV replication (Fig. 6). However, further experi-
ments are required to validate the model. Of note, PKC
has been shown to be involved with cellular apoptosis.
In most contexts, such as in melanoma cell lines [27],
bladder carcinoma cell lines [28], glioma cells [29], and
salivary gland epithelial cells [30], PKC especially PKCα
appeared to inhibit apoptosis (except, in the LNCaP
prostrate cells in which expression of PKCα promotes
apoptosis) [31]. Loss of PKCα activity either induces
death, or sensitizes cells to death signals. Although, our
experiments in hepatocellular carcinoma cells found
that the inhibitions of PKC activity did not cause any
notable cell death under the conditions, it is possible
that PKC may also contribute to suppress host cell loss
by specifically inhibiting apoptosis signal triggered by
DENV infection.
Conclusions
PKC may act as a restricting mechanism that modulates
the DENV replication and represses the viral outburst in
the host cells.
Methods
In vitro kinase assay
The His-tagged NS5 RdRp protein was purified from
bacteria expression following Kamkaew et al. [32]. Den-
gue Capsid, prM, E, NS1, NS2B, NS3 and NS4B coding
DNA were amplified by PCR from pD2-IC plasmid
containing DENV2 genome [33]. The PCR products
were inserted into pGEX-5X-3 plasmid (GE Healthcare
Bio-Sciences). E.coli BL21 (DE3) was used to express
dengue proteins according to standard protocol recom-
mended by the manufacturer. The assay use 1 μg
DENV proteins as substrate in a reaction with 75 ng of
purified human PKC (Sigma). Cdk4/cyclinD1, PKA, CK
I kinases were purchased from Calbiochem, Sigma and
Promega, respectively. The kinase buffers and the reac-
tions were prepared and performed as recommended
by the manufacturer’s protocols. After the kinase reac-
tions, the substrates were run on a 12 % SDS-PAGE
Fig. 6 Inhibition of NS5 phosphorylation by PKC promotes viral
replication. PKC is a host factor, which restricts intracellular DENV2
number by phosphorylating viral NS5. Inhibition of PKC by PKC
inhibitor (BisI) or PKC-specific siRNA (siPKC) results in increased viral
copy number
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gel. Expected bands of substrates were visualized by
Coomassie blue staining and were excised from the gel
to measure the γ-32P incorporation. The γ-32P was de-
tected by scintillation counter (Perkin Elmer).
Cell lines and culture conditions
The human liver hepatocellular carcinoma cell line
HepG2 was a kind gift from Dr. Limjindaporn T, Faculty
of Medicine, Siriraj Hospital, Mahidol University. The
Baby hamster kidney cell line (BHK-21) was a kind gift
from Dr. Leardkamolkarn V, Faculty of Sciences, Mahidol
University. They were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10 % heat-
inactivated fetal bovine serum (FBS), 100 U/ml penicillin
G and 100 μg/ml streptomycin (Invitrogen). Cells were
grown at 37 °C with 5 % CO2 in a humidified incubator.
Recombinant epitope-tagged DENV2
Construction of the recombinant DENV harboring the
His-FLAG-tagged NS5 DENV (etDENV) was described
previously [34]. Briefly, the cDNA from DENV serotype
2 strain 16681 in the pD2-IC plasmid [33] was used as
the template for the insertion of the epitope tag. The
TAP tag comprised of an octahistidine (His8) tag, a tri-
glycine spacer, and FLAG sequence (DYKDDDDK) was
inserted into the NS5 gene in pD2-IC via a standard
QuikChange procedure. The positive clone containing
the tag was verified by DNA sequencing. Wild-type and
tagged DENV RNAs were synthesized according to a
previous report [33]. Assay for viral kinetics was per-
formed as follows: BHK-21 cells were infected with the
viruses, viral titers from day 1 to day 6 post infection
were determined using foci formation assay (FFA). We
found that the recombinant DENV etDENV produced a
comparable kinetic to that of wild type DENV 16681
(Additional file 1: Figure S1) up to 6 days. Once pre-
pared, the viral titration was performed as follows.
Supernatant of transfected infected cells was collected
for FFA at 7 days post transfection. For FFA, the super-
natant was incubated with BHK-21 cells in 96 well plates
for 2 h, and subsequently 200 μl of 1.5 % carboxymethyl-
cellulose (CMC) and 2 % FBS in DMEM was added to
cover the cells, and the cells were incubated at 37 °C for
3 days. The infected BHK-21 cells were then washed
with PBS 3 times and fixed with 3.7 % formaldehyde for
10 min at room temperature. The cells were perme-
abilized by 1 % Triton X-100 in PBS for 10 min and
washed with PBS 5 times. The cells then were incu-
bated with 1:1,000 in PBS anti-DENV E protein (EMD
Milipore). Thereafter, the cells were washed with PBS 5
times before incubation with goat anti-mouse conjugated
horseradish peroxidase (HRP) antibody at a 1:1,000 dilu-
tion for 45 min at 37 °C. The foci were visualized through
SigmaFAST™ DAP (Sigma) and counted under microscopy
to determine viral titter.
Viral infection
In ever experiment, wild type DENV2 strain 16681 [35]
or His-FLAG-tagged DENV was added into host cells at
a multiplicity of infection (MOI) of 1, with an exception
of the experiment with PMA treatment, in which virus
with MOI of 5 was used. Cells were incubated at 37 °C
for 90 min to allow incorporation of virus in to cells be-
fore being washed twice with PBS to remove excess
virus. After that, DMEM medium supplemented with
2 % heat-inactivated FBS was added into the cells. Cells
were further incubated at 37 °C for for time points indi-
cated in the figures.
Computational prediction of phosphorylation sites in
Dengue NS5 protein
Bioinformatics tools used for screening of the possible
PKC sites, Scansite™ 2 [18], NetPhosK 2.0 [19], and
KinasePhos 2.0 [20], were used for predicting phosphor-
ylation sites in Dengue NS5 protein. A high stringency
level was set for Scansite™, whereas a 0.9 threshold
(high) was used for NetphosK, and a 100 % specificity
was used for KinasePhos.
Sequence and structure analysis
To identify the conservation among flaviviruses, DENV1
(P27909), DENV2 (AHG23127), DENV3 (P27915),
DENV4(P09816), West Nile virus (P06935), Japanese En-
cephalitis virus (P27395), yellow fever virus (AAC35930),
St. Louis encephalitis virus (P09732), Omsk hemorrhagic
fever virus (AAR98531), Zika virus (W8R1T1), Gadgets
Gully virus (A0EKU2), Kama virus (W5VRZ2) and tick-
borne encephalitis virus (Q01299) NS5 sequences were
compared by BioEdit 7.2.5. The phospho-conservative site
was shown in crystal structure of NS5 (PDB ID: 4V0R).
Cell viability assay
To assess cytotoxicity of Bisindolylmaleimide I (BisI)
Hydrochloride (Cell signaling) to HepG2 cells, the cells
were seeded in 96-well plates at a density of 104 cells/
well in DMEM medium supplemented with 10 % heat-
inactivated FBS for 24 h before BisI treatment. BisI at
concentrations of 0.001 μM, 0.01 μM, 0.1 μM, and 1 μM
in DMEM medium supplemented with 10 % heat-
inactivated FBS were added onto the cells. DMSO at a
final concentration of 0.5 % served as a vehicle control.
At 24, 48, and 72 h post-treatment, cell viabilities were
assessed by a MTT assay, following the manufacturer
protocol. To assess cytotoxicity of siRNA to HepG2
cells, the cells were seeded in a 96-well plate at a density
of 104 cells/well in DMEM medium supplemented with
10 % heat-inactivated FBS for 24 h before being
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transfected with PKCα siRNA at 24, 48, and 72 h post-
transfection, MTT was added as described above.
Viral replication assay in BisI-treated cells
HepG2 cells (5.5 X 105 cells) were seeded into culture
dishes for 24 h before being treated with various concen-
trations of BisI, i.e. 0.001 μM, 0.01 μM, 0.1 μM, and
1 μM. BisI was added into the cells 30 min before viral
infection. BisI was kept constant in the medium during
infection with DENV2 at MOI of 1. This was followed
by an incubation for 90 min to allow internalization of
virus into cells. After the excess virus was removed, and
the cells were washed twice by PBS, BisI in DMEM sup-
plemented with 2 % FBS was added into cells and fur-
ther incubated for the desired times, before the cells
were harvested for detection of intracellular viral RNA
by RT-qPCR.
Viral replication assay in PKCα–knockdown cells
PKCα siRNA (Santa Cruz biotechnologies, SC-29449) or
Silencer® Negative control siRNA (Thermo, AM4611)
were transfected into HepG2 cells using Lipofectamine®
RNAiMAX reagent (Invitrogen) following the manufac-
turer’s protocol. HepG2 cells (5.5 × 105 cells) were
seeded for 24 h before siRNA complexes were added.
Twenty nM of siRNA were effective for suppressing
PKCα expression. At 24 h post-transfection, DENV2 at
MOI of 1 was added into the HepG2 cells and the cul-
ture was further incubated for 90 min to allow internal-
ization of virus into the cells. Then, the excess virus was
removed, and the cells were washed twice with PBS.
Finally, DMEM supplement with 2 % FBS was added
into the cells, and the cells were further incubated for
another 24 h. Cells were collected for detection of intra-
cellular viral RNA by RT-qPCR and viral proteins by
immunoblots.
Intracellular viral RNA quantification by RT-qPCR
Total RNA was extracted from DENV-infected cells by
Trizol reagent (Invitrogen), according to manufacturer’s
protocol. The reverse transcriptase reaction was set up
using iScriptTM select cDNA synthesis kit (Bio-Rad) for
first-strand cDNA synthesis. One microgram of total RNA
was used as a template for all RT reaction. The reactions
were performed with random primers. qPCR reactions
were carried out using 2X KAPPA SYBR Green (KAPPA
Biosystem). Amplification and detection were performed
using an Applied Biosystems 7500 Real-time PCR system
(ABI, California). qPCR conditions were 95 °C for 3 min,
followed by 40 cycles of 95 °C for 3 s and 60 °C for 1 min.
Primers are:
NS5-Forward primer 5’-TCCATACATGCTAAACATG
A-3’
NS5-Reverse primer 5’-GGGATTTCCTCCCATGATT
CC-3’
β-actin-Forward prime 5’-TCTTCCAGCCTTCCTTC
CT-3’
β-actin-Reverse primer 5’-AGCACTGTGTTGGCGTA
CAG-3’
Western blot analysis
HepG2 cell lysates were suspended in RIPA buffer solu-
tion containing 50 mM Tris-base pH 7.4, 150 mM NaCl,
1 % triton X-100, 0.1 % SDS, 1 % sodium deoxycholate,
1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 1 mM β-
glycerophosphate, 0.5 % NP40, 1 mM PMSF and 7× pro-
tease inhibitor cocktail. Protein samples were mixed with
6× protein loading dye, boiled and separated using SDS-
PAGE. Gel was run for 2 h at 120 V before the proteins
were transferred onto PVDF membrane by semi-dry
blotting for 30 min at 10 V. After the transfer, nonspe-
cific binding was blocked using 5 % skim milk for 1 h at
room temperature. To determine inhibitory activity of
PKC by BisI, after 24 post-infection, primary and sec-
ondary antibodies were rabbit antibodies against p-
PEA15, PEA15, and goat anti rabbit antibody conjugated
with horseradish-peroxidase (HRP) (Thermo scientific),
respectively. To test whether PKCα siRNA can knock
down PKCα after 24 and 48 h post-transfection, expres-
sions of PKCα were detected by using mouse antibody
specific to PKCα, and goat antibody specific to GAPDH
(loading control) (both were from Santa cruz biotech-
nologies) as primary antibodies and goat anti-mouse
(Novagen) and mouse anti-goat antibodies conjugated
with HRP (Santa cruz biotechnologies) as secondary
antibodies. To verify expression of NS5, rabbit antibody
against NS5 (Thermo scientific) was used, followed by
goat anti-rabbit antibody conjugated with HRP as sec-
ondary antibodies. The antigen-antibody complexes were
detected by using chemiluminesence detection (ECL,
Amersham Pharmacia Biotech).
Determination of in vivo phosphorylation of NS5 by PKC
In this test, we performed infection of the recombinant
virus on BHK-21 cells, due to the relatively high expres-
sion level of viral proteins obtained from this cell line.
BHK-21 cells were treated with 1 μM BisI before, at the
time of, and after DENV infection as described above. At
24 h post-infection, cells were washed with cold PBS be-
fore extraction of total protein using CLB buffer (50 mM
Tris HCl PH 7.4, 250 mM NaCl, 5 mM EDTA, 1 mM
Na3VO4, 1 mM NaF, 1 mM β-glycerophosphate, 0.5 %
NP40, 1 mM PMSF and 7X protease inhibitor cocktail).
Three mg of cell lysate were used for FLAG-NS5 immuno-
precipitation (IP) with 20 μl of anti-FLAG M2 affinity gel
(Sigma) in 1 ml reaction according to the manufacturer’s
instruction. IP products were separated by SDS-PAGE and
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transferred onto a PVDF membrane. The membrane was
probed with rabbit anti-NS5 (Thermo scientific), mouse
anti-phospho-Serine or anti-phospho-Threonine (Sigma)
followed by incubation with goat anti-rabbit or goat anti-
mouse IgG conjugated with HRP. The antigen-antibody
complexes were detected by using chemiluminesence de-
tection (ECL, Amersham Pharmacia Biotech).
Statistical analysis
All experiments were performed in triplicate and data
are presented as the mean ± standard deviation (SD).
Statistical comparisons were performed using Student’s
t test. p-value ≤0.05 was considered to indicate a statis-
tically significant difference.
Additional file
Additional file 1: Viral kinetics of wild type DENV 16681, and the
recombinant DENV etDENV. (PDF 63 kb)
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